CClinicalTrials.gg
CompletedNCT02498834Updated Jan 16, 2019Results posted

Using Question Prompt Lists During Pediatric Asthma Visits to Increase Adolescent Involvement

An interventional study of Educational Video and Question Prompt List in Asthma, sponsored by University of North Carolina, Chapel Hill. Completed at 1 site in United States. Open to participants aged 11 Years to 17 Years. Per ClinicalTrials.gov, last updated 2019-01-16.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
359
Allocation
Randomized
Ages
11 Years to 17 Years
Sex
All
01

Study summary

The purpose of this study is to conduct a randomized controlled trial with English and Spanish-speaking adolescents to compare the effectiveness of an adolescent "asthma question prompt list" with a supportive educational video intervention with usual care.

The hypothesis of this study is that by showing the parents and adolescents the educational video and then providing the adolescents with the one-page "asthma question prompt lists" to use during their visits will improve: (a) asthma control, (b) adolescent self-efficacy in managing asthma, and (c) adolescent quality-of-life.

Read the detailed description

The study uses a randomized controlled trial design stratified by provider to assess the impact of an adolescent "asthma question prompt list" combined with a supportive educational video emphasizing the importance of adolescent involvement and question-asking on communication during pediatric visits. This application is based on Social Cognitive Theory. Self-confidence or self-efficacy is a central component of Social Cognitive Theory (SCT) Application of Social Cognitive Theory (SCT) in asthma populations has shown that technical advice from providers is one external factor that can improve asthma management self-efficacy. Additionally, personal beliefs, such as outcome expectations, and family factors, such as parent and adolescent responsibility for asthma self-management, have been shown to affect adolescent self-efficacy and disease management outcomes. Prior work has found that adolescent self-efficacy in asthma management correlates strongly with health status, adherence, asthma medication device technique, asthma symptoms, and impact of illness on the family.

All adolescents will have their medical visits audio recorded. The adolescent will be interviewed after his/her medical visit while his/her caregiver/parent completes a survey at the time of study enrollment. This same procedure will be used when the adolescent and caregiver/parents return for the 6- and 12-month follow-up visits.

02

Conditions studied

  • Asthma

Browse trials for

Keywords

  • Communication
  • provider
  • caregiver
  • adolescent
03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.

This study's enrollment of 359 is above the median of 83 across 2,752 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,340 studies on the registry; 133 are open to participants now.

Of its 155 completed or terminated interventional studies of FDA-regulated products, 136 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ages 11 to 17 years;
  • speak and read English or Spanish;
  • have persistent asthma;
  • are present for an acute or follow-up asthma visit or a well-child visit;
  • and have previously visited the clinic at least once for asthma.

Adolescents' parents will be eligible if they are at least 18 years of age, speak and read English or Spanish, and are the legal guardian of the adolescent.

Exclusion criteria

Exclusion Criteria:

  • present for gastrointestinal complaints or other non-asthma related acute illness.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
359 participants (actual)

Study arms

  • Experimental
    Educational Video and Question Prompt List

    Parents and adolescents in this group will watch a short educational video in English or Spanish on an iPad about the importance of encouraging adolescents to ask questions and to be involved during their pediatric asthma visits to improve their self-management skills. Also, the adolescents in this group will be handed a question prompt list to complete, which will be collected after the medical visit.

    Behavioral: Educational Video and Question Prompt List

  • No intervention
    Control group

    Standard of care will be used

Interventions

  • BehavioralEducational Video and Question Prompt List

    Educational Video and Question Prompt List

06

What researchers measure

Primary outcomes

  1. Number of Participants Achieving Asthma Control

    This will be measured via the 5-item Asthma Control Test, responses are summed to indicate a score ranging from 5 (poor asthma control) to 25 (complete asthma control). A higher score means a better outcome. A score of above 19 is considered "well controlled".

    Time frame: 12 month follow-up

  2. Adolescent Asthma Management Self-efficacy Score

    Adolescent asthma management self-efficacy was measured using a 14-item scale that has been shown to have a reliability of 0.87. Prior work in asthma has found asthma management self-efficacy to change in response to an intervention. Scores range from 14 to 70 and a higher score means a better outcome.

    Time frame: 12 month follow-up

  3. Asthma Quality-of-life Score

    Adolescent quality-of-life was measured as a continuous variable. The investigators used the standardized version of the Juniper pediatric asthma quality-of-life questionnaire. The questionnaire contains 23 items and has a reliability of 0.84. Scores can range from 1.0 to 7.0, and a higher score means a better outcome.

    Time frame: 12 month follow-up

07

Results

Posted Jan 16, 2019

Participant flow

Participant flow — Overall Study
MilestoneEducational Video and Question Prompt ListControl Group
Started185174
Completed175164
Not completed1010

Outcome measures

PrimaryNumber of Participants Achieving Asthma Control

This will be measured via the 5-item Asthma Control Test, responses are summed to indicate a score ranging from 5 (poor asthma control) to 25 (complete asthma control). A higher score means a better outcome. A score of above 19 is considered "well controlled".

Time frame:
12 month follow-up
Reported as:
Count of participants · Participants
Number of Participants Achieving Asthma Control
ParticipantsEducational Video and Question Prompt ListControl Group
Controlled121128
Not controlled5336
PrimaryAdolescent Asthma Management Self-efficacy Score

Adolescent asthma management self-efficacy was measured using a 14-item scale that has been shown to have a reliability of 0.87. Prior work in asthma has found asthma management self-efficacy to change in response to an intervention. Scores range from 14 to 70 and a higher score means a better outcome.

Time frame:
12 month follow-up
Reported as:
Mean · score on a scale
Adolescent Asthma Management Self-efficacy Score
score on a scaleEducational Video and Question Prompt ListControl Group
Adolescent Asthma Management Self-efficacy Score58.9 ± 8.659.7 ± 7.2
PrimaryAsthma Quality-of-life Score

Adolescent quality-of-life was measured as a continuous variable. The investigators used the standardized version of the Juniper pediatric asthma quality-of-life questionnaire. The questionnaire contains 23 items and has a reliability of 0.84. Scores can range from 1.0 to 7.0, and a higher score means a better outcome.

Time frame:
12 month follow-up
Reported as:
Mean · score on a scale
Asthma Quality-of-life Score
score on a scaleEducational Video and Question Prompt ListControl Group
Asthma Quality-of-life Score6.1 ± 1.26.2 ± 0.98

Adverse events

Collected over Up to approximately 1 year following enrollment. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Educational Video and Question Prompt List0/185 (0%)0/185 (0%)0/185 (0%)
Control Group0/174 (0%)0/174 (0%)0/174 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Educational Video and Question Prompt ListControl GroupTotal
Mean13.2 ± 1.913.2 ± 1.913.2 ± 1.9
Sex: Female, Male
Sex: Female, Male(Participants)Educational Video and Question Prompt ListControl GroupTotal
Female7678154
Male10996205
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Educational Video and Question Prompt ListControl GroupTotal
Hispanic or Latino261945
Not Hispanic or Latino159155314
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Educational Video and Question Prompt ListControl GroupTotal
American Indian or Alaska Native241741
Asian044
Native Hawaiian or Other Pacific Islander000
Black or African American7163134
White6070130
More than one race000
Unknown or Not Reported302050
Region of Enrollment
Region of Enrollment(Participants)Educational Video and Question Prompt ListControl GroupTotal
United States185174359
Number of Participants Achieving Asthma Control
Number of Participants Achieving Asthma Control(Participants)Educational Video and Question Prompt ListControl GroupTotal
Controlled101105206
Not controlled8469153
Adolescent asthma management self-efficacy score
Adolescent asthma management self-efficacy score(score on a scale)Educational Video and Question Prompt ListControl GroupTotal
Mean55.9 ± 8.056.0 ± 8.255.9 ± 8.1
Asthma quality-of-life score
Asthma quality-of-life score(score on a scale)Educational Video and Question Prompt ListControl GroupTotal
Mean5.7 ± 1.25.8 ± 1.25.7 ± 1.2
08

Study locations

1 site
  • University of North Carolin at Chapel Hill
    Chapel Hill, North Carolina 27599, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Apr 27, 2015

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 16, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02498834
Lead sponsor
University of North Carolina, Chapel Hill
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Sponsor
First posted
Jul 15, 2015
Start date
Jul 2015
Primary completion
Nov 2017
Completion
Nov 2017
Results posted
Jan 16, 2019
Last update
Jan 16, 2019

Study contacts

Betsy L Sleath, PhD
principal investigator · University of North Carolina, Chapel Hill

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion